<!DOCTYPE html>
<html>
  <head>
    <title>Headache</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta charset="utf-8">
    <!-- Bootstrap -->
    <link href="//netdna.bootstrapcdn.com/bootswatch/3.2.0/flatly/bootstrap.min.css" rel="stylesheet" media="screen">
    <link href="/css/site.css" rel="stylesheet" media="screen">
    <link href="/css/syntax.css" rel="stylesheet" media="screen">

    <!-- HTML5 Shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
    <!--[if lt IE 9]>
      <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
      <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->
<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-48968311-4', 'jandecaluwe.com');
  ga('send', 'pageview');

</script>
  </head>

  <body>

    <!-- Fixed navbar -->
    <div class="navbar navbar-default navbar-fixed-top">
      <div class="container">
        <div class="navbar-header">
          <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </button>
          <a class="navbar-brand" href="/">Rory’s notes</a>
        </div>
        <div class="navbar-collapse collapse">

          <ul class="nav navbar-nav navbar-left">
 
          </ul>

          <ul class="nav navbar-nav navbar-right">
            <li class="active"><a href="/notes/">notes</a></li>
          </ul>

        </div><!--/.nav-collapse -->
      </div>
    </div>


<div class="container">

  <ol class="breadcrumb">
    <li><a href="/">Home</a></li>
      <li><a href="/notes/">notes</a></li>
      <li><a href="/notes/neurology/">neurology</a></li>
      <li><a href="/notes/neurology/brain_trauma/">brain_trauma</a></li>
      <li class="active">Headache</li>
  </ol>

  <div class="page-header">
 
    <h1>Headache</h1>
  </div>

  <div class="row">

    <div class="col-md-3" role="navigation"> 
 
      <div class="sidebar" data-spy="affix" data-offset-top="80" data-offset-bottom="60">
        <div class="well">
          <a href="#"><strong>Headache</strong></a>
          <div class="toc">
<ul>
<li><a href="#red-flags">Red flags</a><ul>
<li><a href="#age">Age</a></li>
<li><a href="#characteristics">Characteristics</a></li>
<li><a href="#additional-features">Additional features</a></li>
</ul>
</li>
<li><a href="#serious-causes">serious causes:</a></li>
<li><a href="#history">history</a></li>
<li><a href="#minimal-examination">minimal examination</a></li>
<li><a href="#migraine">Migraine</a><ul>
<li><a href="#ihs-diagnositc-criteria-migraine-without-aura">IHS diagnositc criteria - migraine without aura</a></li>
<li><a href="#migraine-with-aura">Migraine with aura</a></li>
<li><a href="#managmenet">managmenet</a></li>
</ul>
</li>
<li><a href="#tension-type-headache">Tension type headache</a><ul>
<li><a href="#management">management</a></li>
</ul>
</li>
<li><a href="#cluster-headache">Cluster headache</a><ul>
<li><a href="#managment">managment</a></li>
</ul>
</li>
<li><a href="#medication-overuse-headahce">medication overuse headahce</a></li>
</ul>
</div>

        </div>
      </div>
    </div>
 
    <div class="content">
      <div class="col-md-6" role="main">
        <blockquote>
<p>primary or secondary</p>
</blockquote>
<p>BASH(http://www.bash.org.uk/wp-content/uploads/2012/07/10102-BASH-Guidelines-update-2_v5-1-indd.pdf)</p>
<h3 id="red-flags">Red flags</h3>
<h4 id="age">Age</h4>
<ul>
<li>
<p>new onset >50yo</p>
</li>
<li>
<p>new onset \&lt;10yo</p>
</li>
</ul>
<h4 id="characteristics">Characteristics</h4>
<ul>
<li>
<p>headache new or unexpected</p>
</li>
<li>
<p>progressive headahce - worsening over weeks or longer</p>
</li>
<li>
<p>Persistent headache precipitiated by Valsalva  + postural</p>
</li>
<li>
<p>Thunderclap headahce</p>
</li>
<li>
<p>persistent morning headache with nausea</p>
</li>
</ul>
<h4 id="additional-features">Additional features</h4>
<ul>
<li>
<p>headache with atypical aura</p>
<ul>
<li>
<p>duration >1hr</p>
</li>
<li>
<p>motor weakness</p>
</li>
</ul>
</li>
<li>
<p>Aura for first time in a patient during use of COC</p>
</li>
<li>
<p>new onset headahce in apatient with history of cancer</p>
</li>
<li>
<p>new onset headhace in patient with history of HIV</p>
</li>
<li>
<p>neurological signs</p>
</li>
<li>
<p>seizures</p>
</li>
<li>
<p>symptoms/signs of GCA</p>
</li>
</ul>
<blockquote>
<p>slow growing frontal lobe tumours particularly liable to be silent</p>
<p>present with non-specific headache and subtle personality changes</p>
</blockquote>
<h3 id="serious-causes">serious causes:</h3>
<ol>
<li>
<p>intracranial tumours</p>
</li>
<li>
<p>meningitis</p>
</li>
<li>
<p>subarachnoid haemorrhage</p>
</li>
<li>
<p>GCA</p>
</li>
<li>
<p>Primary angle-closure glaucoma</p>
</li>
<li>
<p>Idopathic intracranial hypertension</p>
<ol>
<li>
<p>young woemn</p>
</li>
<li>
<p>strongly associated with obesity</p>
</li>
<li>
<p>papilloedema present</p>
</li>
</ol>
</li>
<li>
<p>CO poisoning</p>
</li>
</ol>
<h3 id="history">history</h3>
<ul>
<li>
<p>how many different headahce types?</p>
</li>
<li>
<p>Time questions</p>
<ul>
<li>
<p>why now?</p>
</li>
<li>
<p>recent?</p>
</li>
<li>
<p>frequnet/temporal?</p>
</li>
<li>
<p>long lastign?</p>
</li>
</ul>
</li>
<li>
<p>Character questions</p>
<ul>
<li>
<p>intensity?</p>
</li>
<li>
<p>nature/quality?</p>
</li>
<li>
<p>site adn spread of pain</p>
</li>
<li>
<p>associated symptoms</p>
</li>
</ul>
</li>
<li>
<p>Cause</p>
<ul>
<li>
<p>predisposing/trigger</p>
</li>
<li>
<p>Aggravating and/or relieving factors</p>
</li>
<li>
<p>FHx similar</p>
</li>
</ul>
</li>
<li>
<p>Response</p>
<ul>
<li>
<p>what does patient do </p>
</li>
<li>
<p>how much activit/function limited</p>
</li>
<li>
<p>medications</p>
</li>
</ul>
</li>
<li>
<p>state of health between attacks</p>
<ul>
<li>
<p>well/residual/persisting</p>
</li>
<li>
<p>concerns/anxieiteis, fears about recurrent attacks</p>
</li>
</ul>
</li>
</ul>
<h3 id="minimal-examination">minimal examination</h3>
<ul>
<li>
<p>Fundoscpy</p>
</li>
<li>
<p>visual acuity</p>
</li>
<li>
<p>bp</p>
</li>
<li>
<p>examination of head and neck for muscle tenderness, stiffness, ROM and crep</p>
</li>
<li>
<p>Headache diary are useful</p>
</li>
</ul>
<h3 id="migraine">Migraine</h3>
<ul>
<li>
<p>typically:</p>
<ul>
<li>
<p>recurrent episodic moderate or sevrere headahces (may be unilateral and/or pulsating) lasting part of a day or up to 3 days</p>
<ul>
<li>
<p>associated with GI symptoms</p>
</li>
<li>
<p>limit activity and prefer dark and quiet</p>
</li>
</ul>
</li>
<li>
<p>free from symptoms between attacks</p>
</li>
</ul>
</li>
<li>
<p>features common in migraine but not usual in TTH</p>
<ul>
<li>
<p>aura - 1/3</p>
</li>
<li>
<p>unilateral headache</p>
</li>
<li>
<p>hypersensitivity</p>
</li>
<li>
<p>GI symptoms</p>
</li>
</ul>
</li>
</ul>
<h4 id="ihs-diagnositc-criteria-migraine-without-aura">IHS diagnositc criteria - migraine without aura</h4>
<ul>
<li>
<p>at least 5 attacks</p>
</li>
<li>
<p>last 4-72hrs</p>
</li>
<li>
<p>headaches have ≥ 2:</p>
<ul>
<li>
<p>unilateral</p>
</li>
<li>
<p>pulsating</p>
</li>
<li>
<p>moderate/severe</p>
</li>
<li>
<p>aggravation by or causing avoidacne of routine physical activity</p>
</li>
</ul>
</li>
<li>
<p>During headahce ≥ 1</p>
<ul>
<li>
<p>N and or V</p>
</li>
<li>
<p>photophobia/phonophobia</p>
</li>
</ul>
</li>
<li>
<p>not anything else</p>
</li>
</ul>
<h4 id="migraine-with-aura">Migraine with aura</h4>
<ul>
<li>
<p>1/3 of migraine sufferers</p>
</li>
<li>
<p>typical aura</p>
<ul>
<li>
<p>5-60mins</p>
</li>
<li>
<p>visual blurring and ‘spots’ are not diagnostic</p>
</li>
<li>
<p>transient hemianopic disturbacne or scintillating scotoma</p>
</li>
<li>
<p>some cases vidual symptoms</p>
<ul>
<li>together or in sequence with other reversible focal neurological distrubances</li>
</ul>
</li>
</ul>
</li>
<li>
<p>in older patients</p>
<ul>
<li>
<p>visual migranous aura may occur wihotu any further development of a migraine attach</p>
</li>
<li>
<p>not alarming</p>
</li>
</ul>
</li>
<li>
<p>may have attacks of migraine with or without aura</p>
</li>
</ul>
<h4 id="managmenet">managmenet</h4>
<ol>
<li>
<p>lifestyle/avoid triggers</p>
<ol>
<li>
<p>stress</p>
</li>
<li>
<p>depression</p>
</li>
<li>
<p>anxiety</p>
</li>
<li>
<p>head/neck trauma</p>
</li>
<li>
<p>menopause</p>
</li>
<li>
<p>bright lights/loud noise</p>
</li>
<li>
<p>dietary triggers</p>
<ol>
<li>
<p>etoh</p>
</li>
<li>
<p>cheese</p>
</li>
</ol>
</li>
<li>
<p>unaccustomed strenuous exercise</p>
</li>
</ol>
</li>
<li>
<p>Acute</p>
<ol>
<li>
<p>Step 1: Simple oral analgesic +/- anti-emetic</p>
<ol>
<li>
<p>aspirin, ibuprofen</p>
<ol>
<li>
<p>without codeine</p>
</li>
<li>
<p>early in the attack</p>
<ol>
<li>absorption less affected by gastric stasis</li>
</ol>
</li>
</ol>
</li>
<li>
<p>prochlopreaizne </p>
</li>
<li>
<p>domperidone</p>
</li>
<li>
<p>metoclopramide</p>
<ol>
<li>
<p>promotes gastric emptying</p>
</li>
<li>
<p>even when N+V not present</p>
</li>
<li>
<p>on its own gives relief</p>
</li>
</ol>
</li>
<li>
<p>(Step 2: rectal analgesic +/- anti-emetic)</p>
</li>
</ol>
</li>
<li>
<p>Tier 2: specific antimigraine</p>
<ol>
<li>
<p>Triptans</p>
<ol>
<li>
<p><strong>Sumatriptam</strong></p>
<ol>
<li>
<p>50mg orally</p>
<ol>
<li>100mg can be triedin future attacks if 50mg ineffective</li>
</ol>
</li>
<li>
<p>6mg sub cut</p>
</li>
</ol>
</li>
<li>
<p><strong>Rizatriptan</strong></p>
<ol>
<li><em>Rizamelt</em> 10mg orodispersable</li>
</ol>
</li>
<li>
<p>unpredictable individual variations in response to different triptans</p>
</li>
<li>
<p>taken at start of headache phase</p>
<ol>
<li>ineffective during aura</li>
</ol>
</li>
<li>
<p>associated with reutrn of symptoms wihitn 48hrs </p>
<ol>
<li>20-50% who initially respond</li>
</ol>
</li>
<li>
<p>take with metoclopramide</p>
</li>
<li>
<p>contraindicated:</p>
<ol>
<li>
<p>cerebrovascular disease</p>
</li>
<li>
<p>coronary heart disease</p>
</li>
<li>
<p>uncontrolled hypertension</p>
</li>
<li>
<p>severe hepatic impairment</p>
</li>
<li>
<p>concurrent use or use within 2 weeks after discontinuation of MAOi</p>
</li>
</ol>
</li>
<li>
<p>second dose only if first dose effective</p>
</li>
</ol>
</li>
<li>
<p>Ergotamine</p>
<ol>
<li>
<p>limited by significant risk of toxicity and drug interactions</p>
</li>
<li>
<p>side effects</p>
<ol>
<li>
<p>n &amp; v</p>
</li>
<li>
<p>parasthesia</p>
</li>
<li>
<p>convulsive and gangrenous effects of erotism</p>
</li>
</ol>
</li>
<li>
<p>Contraindications</p>
<ol>
<li>
<p>cardiovascular and cerebrovascular diseases</p>
</li>
<li>
<p>Raynaud’s diseaese</p>
</li>
<li>
<p>arterial htn</p>
</li>
<li>
<p>renal failure</p>
</li>
<li>
<p>pregnancy</p>
</li>
<li>
<p>breast feeding</p>
</li>
</ol>
</li>
<li>
<p>lower relapse rate compared to sumtripatn</p>
</li>
<li>
<p>may be useful if relapse an issue</p>
</li>
<li>
<p>available with caffeine</p>
<ol>
<li>
<p><strong>cafergot</strong></p>
</li>
<li>
<p>1mg ergotamine, 100mg caffeine</p>
</li>
<li>
<p>2 intially then further 1 30 mins if needed</p>
</li>
<li>
<p>max dose in 24horus = 6mg and max 10/week</p>
</li>
</ol>
</li>
</ol>
</li>
</ol>
</li>
<li>
<p>step 4:</p>
<ol>
<li>
<p>combination</p>
</li>
<li>
<p>chlorpromazine</p>
</li>
<li>
<p>avoid opiate</p>
</li>
</ol>
</li>
</ol>
</li>
<li>
<p>Prophylaxis</p>
<ol>
<li>
<p>reduce number of attacks</p>
</li>
<li>
<p>6-8wks reasonable </p>
</li>
<li>
<p>First line</p>
<ol>
<li>
<p>Betablockers</p>
<ol>
<li>atenolol > metoprolol > propranolol</li>
</ol>
</li>
<li>
<p>Amitriptyline 10-150mg daily</p>
<ol>
<li>
<p>first line when:</p>
<ol>
<li>
<p>troublesome TTH</p>
</li>
<li>
<p>chronic pain</p>
</li>
<li>
<p>disturbed sleep</p>
</li>
<li>
<p>depression</p>
</li>
</ol>
</li>
</ol>
</li>
</ol>
</li>
<li>
<p>Second line:</p>
<ol>
<li>
<p>topiramate</p>
<ol>
<li>
<p>enzyme inducer</p>
<ol>
<li>
<p>reduces efficacy of OCP</p>
</li>
<li>
<p>unlikely to have clinically signifiant effect on hormonal contraception @ doses \&lt; 100mg /day</p>
</li>
</ol>
</li>
</ol>
</li>
<li>
<p>sodium valproate</p>
</li>
</ol>
</li>
<li>
<p>Third line</p>
<ol>
<li>
<p>Gabapentin</p>
</li>
<li>
<p>combine betablockers and amitrip</p>
</li>
</ol>
</li>
</ol>
</li>
</ol>
<h3 id="tension-type-headache">Tension type headache</h3>
<ul>
<li>
<p>episodic tension type headahce</p>
<ul>
<li>
<p>attack like episdoes</p>
</li>
<li>
<p>variable often very low frequncy and short lasting</p>
</li>
<li>
<p>may be unilateral</p>
</li>
<li>
<p>more often generalised</p>
</li>
<li>
<p>pressure/tightness</p>
</li>
<li>
<p>spreads into or arises from neck</p>
</li>
<li>
<p>stress or associated with functional or structural msk abnormal</p>
</li>
</ul>
</li>
<li>
<p>chronic tension type headache</p>
<ul>
<li>
<p>>15d / month</p>
</li>
<li>
<p>may be daily</p>
</li>
</ul>
</li>
</ul>
<h4 id="management">management</h4>
<ul>
<li>
<p>simple analgeisa</p>
</li>
<li>
<p>nsaids</p>
</li>
<li>
<p>paracetamol less effective</p>
</li>
<li>
<p>amitriptyline</p>
</li>
<li>
<p>botulinum ineffective</p>
</li>
</ul>
<p>- </p>
<h3 id="cluster-headache">Cluster headache</h3>
<ul>
<li>
<p>trigminal autonomic cephalalgias</p>
<ul>
<li>daily occurence of headache usual</li>
</ul>
</li>
<li>
<p>mostly affects men</p>
<ul>
<li>
<p>6:1</p>
</li>
<li>
<p>in 20s</p>
</li>
</ul>
</li>
<li>
<p>occur in bouts for 6-12 weeks once/year or 2 years - often @ same time</p>
</li>
<li>
<p>intesne pain</p>
</li>
<li>
<p>strictly unilatearl</p>
<ul>
<li>most often focused in 1 or other eye</li>
</ul>
</li>
<li>
<p>daily at similar time</p>
</li>
<li>
<p>often at 1-2 hrs after falling asleep</p>
</li>
<li>
<p>patient unable to stay in bed, paces room</p>
</li>
<li>
<p>may beat head on wall or floor - 30-60mins</p>
</li>
<li>
<p>autonomic</p>
<ul>
<li>
<p>ipsilateral conuunctival injection</p>
</li>
<li>
<p>lacrimation</p>
</li>
<li>
<p>rhinorrhoea</p>
</li>
<li>
<p>nasal blockage</p>
</li>
<li>
<p>ptosis</p>
</li>
</ul>
</li>
</ul>
<h4 id="managment">managment</h4>
<ul>
<li>
<p>Reassurance</p>
</li>
<li>
<p>Oxygen</p>
</li>
<li>
<p>Prophlactic</p>
<ul>
<li>
<p>verapamil</p>
</li>
<li>
<p>prednisone</p>
</li>
<li>
<p>lithium</p>
</li>
</ul>
</li>
<li>
<p>acute</p>
<ul>
<li>
<p>sumatriptan</p>
</li>
<li>
<p>oxygen</p>
</li>
<li>
<p>analgesia has no place</p>
</li>
</ul>
</li>
</ul>
<h3 id="medication-overuse-headahce">medication overuse headahce</h3>
<ul>
<li>
<p>1:50 adults suffer</p>
</li>
<li>
<p>combination analgesics prime candidates for development of MOH</p>
</li>
<li>
<p>regular intake of simple anagesics on 15 or more days / month or codeine/triptan/ergot on 10 or more day s/ month</p>
</li>
<li>
<p>low doses daily >> larger doses weekly</p>
</li>
<li>
<p>highly variable headache</p>
<ul>
<li>
<p>oppressive, presenta nd worset on awakening in morining</p>
</li>
<li>
<p>increases physical exertion</p>
</li>
</ul>
</li>
<li>
<p>change to pre-emptive abalgesia = key</p>
</li>
</ul>
<p>end</p>
      </div>
    </div>

  </div>
    

    <div class="footer">
        <p>Website powered by <a href="http://urubu.jandecaluwe.com">Urubu</a></p>
    </div>


</div> 


    <!-- jQuery (necessary for Bootstrap's JavaScript plugins) -->
    <script src="https://code.jquery.com/jquery.js"></script>
    <!-- Include all compiled plugins (below), or include individual files as needed -->
    <script src="//netdna.bootstrapcdn.com/bootstrap/3.2.0/js/bootstrap.min.js"></script>

  </body>
</html>
